GPCR/G protein


All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B8360 CPI-444Summary: An A2A receptor antagonist for tumor immunology and adenosine pathway research. -
BA1266 SucralfateSummary: Sucralfate(Sucroseocta sulfate-aluminum complex) -
BA1297 ChlorphenesinSummary: Chlorphenesin is a reversible antigen-related immunosuppressant. -
BA7349 9-FluorenolSummary: 9-Fluorenol (9-Hydroxyfluorene) is a (dopamine) inhibitor. -
C3249 (S)-(+)-MethopreneSummary: A juvenile hormone analog insecticide that can prevent insects from transforming from pupae into adults. -
C3338 VincamineSummary: An alkaloid with cerebral vasodilatory effects and improved glucose homeostasis. -
C3346 Pinolenic AcidSummary: A polyunsaturated fatty acid that can lower cholesterol levels and reduce appetite. -
C3949 FTY720 (S)-PhosphateSummary: Immunomodulator; potent S1P1, S1P3, S1P4 and S1P5 agonist -
C3950 SB-207266Summary: Selective 5-HT4 receptor antagonist. -
C4010 Lyso-SphingomyelinSummary: A bioactive sphingolipid involved in the regulation of cell signaling, tumors, and inflammation.

